These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30197188)

  • 21. Effect of prophylactic intraocular pressure-lowering medication on intraocular pressure spikes after intravitreal injections.
    Frenkel MP; Haji SA; Frenkel RE
    Arch Ophthalmol; 2010 Dec; 128(12):1523-7. PubMed ID: 21149773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of elevated intraocular pressure after intravitreal injection in Japanese patients with age-related macular degeneration.
    Maruyama-Inoue M; Inoue T; Mohamed S; Kitajima Y; Ikeda S; Ito A; Kadonosono K
    Sci Rep; 2021 Jun; 11(1):12246. PubMed ID: 34112856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of selective laser trabeculoplasty on intraocular pressure in patients with intravitreal steroid-induced elevated intraocular pressure.
    Rubin B; Taglienti A; Rothman RF; Marcus CH; Serle JB
    J Glaucoma; 2008; 17(4):287-92. PubMed ID: 18552614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prevention of intraocular pressure elevation following intravitreal injections].
    Budzinskaya MV; Shelankova AV; Andreeva YS
    Vestn Oftalmol; 2022; 138(5. Vyp. 2):240-246. PubMed ID: 36287162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repeated intravitreous ranibizumab injections for diabetic macular edema and the risk of sustained elevation of intraocular pressure or the need for ocular hypotensive treatment.
    Bressler SB; Almukhtar T; Bhorade A; Bressler NM; Glassman AR; Huang SS; Jampol LM; Kim JE; Melia M;
    JAMA Ophthalmol; 2015 May; 133(5):589-97. PubMed ID: 25719991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term intraocular pressure changes after intravitreal injection of bevacizumab.
    Baek SU; Park IW; Suh W
    Cutan Ocul Toxicol; 2016 Dec; 35(4):310-4. PubMed ID: 26820610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of ocular rigidity with intraocular pressure spike after intravitreal injection of bevacizumab in exudative retinal disease.
    Sayah DN; Szigiato AA; Mazzaferri J; Descovich D; Duval R; Rezende FA; Costantino S; Lesk MR
    Br J Ophthalmol; 2021 Mar; 105(3):392-396. PubMed ID: 32345604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repeated intravitreal anti-vascular endothelial growth factor injections can induce iatrogenic ocular hypertension, especially in patients with open-angle glaucoma.
    Agard E; Elchehab H; Ract-Madoux G; Russo A; Lagenaite C; Dot C
    Can J Ophthalmol; 2015 Apr; 50(2):127-31. PubMed ID: 25863852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The acute and chronic effects of intravitreal anti-vascular endothelial growth factor injections on intraocular pressure: A review.
    Bracha P; Moore NA; Ciulla TA; WuDunn D; Cantor LB
    Surv Ophthalmol; 2018; 63(3):281-295. PubMed ID: 28882597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of immediate and sustained intraocular pressure rise associated with intravitreal antivascular endothelial growth factor injection therapy.
    Aref AA
    Curr Opin Ophthalmol; 2012 Mar; 23(2):105-10. PubMed ID: 22249237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and management of elevated intraocular pressure with antivascular endothelial growth factor agents.
    Abedi G; Adelman RA; Salim S
    Semin Ophthalmol; 2013 May; 28(3):126-30. PubMed ID: 23631423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The early effects of intravitreal anti vascular endothelial growth factor agents on intraocular pressure and central corneal thickness.
    Omay E; Elgin U; Sen E; Yilmazbas P
    Int Ophthalmol; 2016 Oct; 36(5):665-70. PubMed ID: 26780098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of antiglaucoma agents on short-term intraocular pressure fluctuations after intravitreal bevacizumab injections.
    Shoeibi N; Ghosi Z; Jafari H; Omidtabrizi A
    Int Ophthalmol; 2021 Mar; 41(3):1081-1090. PubMed ID: 33389369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intraocular Pressure Changes in Non-Glaucomatous Patients Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Agents.
    Kiddee W; Montriwet M
    PLoS One; 2015; 10(9):e0137833. PubMed ID: 26360382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Late steroid-induced ocular hypertension after intravitreal dexamethasone implants: A series of 20 cases].
    Billant J; Douma I; Agard E; Levron A; Bouvarel H; Leroux P; Badri Y; Dot C
    J Fr Ophtalmol; 2023 Nov; 46(9):1039-1046. PubMed ID: 37758545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phaco-non-penetrating deep sclerectomy in ocular hypertension secondary to dexamethasone intravitreal implant.
    Pérez-Sarriegui A; Casas-Llera P; Díez-Álvarez L; Contreras I; Moreno-López M; Figueroa MS; González-Martín-Moro J; Muñoz-Negrete FJ; Rebolleda G
    Arch Soc Esp Oftalmol (Engl Ed); 2018 Dec; 93(12):580-585. PubMed ID: 30266279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term effects and safety of an acute increase of intraocular pressure after intravitreal bevacizumab injection on corneal endothelial cells.
    Park J; Lee M
    BMC Ophthalmol; 2018 Jan; 18(1):17. PubMed ID: 29368595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term effects of multiple intravitreal antivascular endothelial growth factor injections on intraocular pressure.
    Kim YJ; Sung KR; Lee KS; Joe SG; Lee JY; Kim JG; Yoon YH
    Am J Ophthalmol; 2014 Jun; 157(6):1266-1271.e1. PubMed ID: 24561173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current intravitreal therapy and ocular hypertension: A review.
    Sudhalkar A; Bilgic A; Vasavada S; Kodjikian L; Mathis T; de Ribot FM; Papakostas T; Vasavada V; Vasavada V; Srivastava S; Bhojwani D; Ghia P; Sudhalkar A
    Indian J Ophthalmol; 2021 Feb; 69(2):236-243. PubMed ID: 33463565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraocular Pressure Elevation Following Intravitreal Anti-VEGF Injections: Short- and Long-term Considerations.
    Levin AM; Chaya CJ; Kahook MY; Wirostko BM
    J Glaucoma; 2021 Dec; 30(12):1019-1026. PubMed ID: 34086610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.